2024 NCLM | Sekbio Offers Immunoassay CDMO One-Stop Solution for Immunoassay Reagents
The 18th National Clinical Laboratory Medicine Conference, organized by the Chinese Medical Association, took place from August 22-24, 2024, at the Hangzhou International Expo Center, situated along the Qiantang River in Hangzhou. This prestigious conference, the highest-level and largest-scale event in the field of clinical laboratory medicine in China, covered the latest research developments and future trends in clinical testing and laboratory management. The event featured keynote presentations from leading experts both domestically and internationally, as well as sessions where peers shared their insights and experiences.
Exhibition Overview
During the conference, Sekbio showcased Immunoassay CDMO: One-Stop Solution for Immunoassay Reagents. Our services cover the entire product lifecycle, including design and development, NMPA registration, CRO services, contract manufacturing, and market launch. With four advanced technology platforms, state-of-the-art equipment, and a highly experienced technical team, Sekbio supports rapid project implementation.
Exhibition Highlights
Our immunoassay products, including those based on chemiluminescence and fluorescence immunochromatography, attracted significant interest from attendees. We engaged in valuable product discussions, shared industry insights, and explored technological advancements with many visitors, resulting in a highly successful and enriching experience.
Closing Remarks
As the 2024 National Clinical Laboratory Medicine Conference concludes, Sekbio remains committed to enhancing diagnostic accuracy. We continue to advance in the field of immunodiagnostics and strive to contribute more high-quality immunoassay products to the IVD industry and to human health.
We look forward to seeing you at the 2025 NCLM!
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics